Emergent BioSolutions Inc (EBS)
3.89
+0.59
(+17.88%)
USD |
NYSE |
May 03, 16:00
3.93
+0.04
(+1.03%)
After-Hours: 20:00
Emergent BioSolutions Cash from Operations (Quarterly): 32.10M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.10M |
| September 30, 2023 | 60.00M |
| June 30, 2023 | -114.40M |
| March 31, 2023 | -184.00M |
| December 31, 2022 | 92.80M |
| September 30, 2022 | -74.00M |
| June 30, 2022 | -15.60M |
| March 31, 2022 | -37.30M |
| December 31, 2021 | 328.10M |
| September 30, 2021 | 16.70M |
| June 30, 2021 | -29.70M |
| March 31, 2021 | 5.10M |
| December 31, 2020 | 246.00M |
| September 30, 2020 | 105.20M |
| June 30, 2020 | 127.90M |
| March 31, 2020 | 57.80M |
| December 31, 2019 | 122.10M |
| September 30, 2019 | -3.10M |
| June 30, 2019 | -35.80M |
| March 31, 2019 | 104.80M |
| December 31, 2018 | -165.80M |
| September 30, 2018 | 174.00M |
| June 30, 2018 | 34.60M |
| March 31, 2018 | -1.00M |
| December 31, 2017 | 77.49M |
| Date | Value |
|---|---|
| September 30, 2017 | 34.94M |
| June 30, 2017 | 54.00M |
| March 31, 2017 | 41.67M |
| December 31, 2016 | -12.65M |
| September 30, 2016 | 27.08M |
| June 30, 2016 | -1.996M |
| March 31, 2016 | 42.17M |
| December 31, 2015 | 1.128M |
| September 30, 2015 | 104.76M |
| June 30, 2015 | 2.503M |
| March 31, 2015 | -65.87M |
| December 31, 2014 | 51.82M |
| September 30, 2014 | 78.92M |
| June 30, 2014 | 10.82M |
| March 31, 2014 | -29.24M |
| December 31, 2013 | 8.641M |
| September 30, 2013 | 60.12M |
| June 30, 2013 | 32.83M |
| March 31, 2013 | -4.626M |
| December 31, 2012 | -39.02M |
| September 30, 2012 | 46.48M |
| June 30, 2012 | 18.34M |
| March 31, 2012 | 13.84M |
| December 31, 2011 | 36.93M |
| September 30, 2011 | 4.662M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-184.00M
Minimum
Mar 2023
328.10M
Maximum
Dec 2021
36.84M
Average
16.70M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Avid Bioservices Inc | 3.687M |
| Viking Therapeutics Inc | -6.134M |
| FibroGen Inc | -18.32M |
| Avinger Inc | -3.389M |
| RAPT Therapeutics Inc | -27.75M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -11.40M |
| Cash from Financing (Quarterly) | 4.70M |
| Free Cash Flow | -257.90M |
| Free Cash Flow Per Share (Quarterly) | 0.3973 |
| Free Cash Flow to Equity (Quarterly) | 22.30M |
| Free Cash Flow to Firm (Quarterly) | 40.41M |
| Free Cash Flow Yield | -129.5% |